德琪（浙江）医药科技有限公司 Deqi (zhejiang) Pharmaceutical Technology Co. LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Antengene's New Drug Discovery Center Established in Zhangjiang, Shanghai: Dedicated to the Research and Development of Innovative Therapies for Cancer 2020-10-12 20:00
Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies 2020-08-13 06:00
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization 2020-07-20 08:00
Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development 2020-07-13 06:00
­Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions 2020-07-02 08:16
Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer 2020-06-08 20:00
Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets 2020-05-05 20:30
Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma 2020-04-14 21:15
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions 2020-04-13 20:00
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors 2020-01-08 20:00
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer 2020-01-06 20:00
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364 2019-11-07 01:40
Antengene Corporation Announces Establishment of U.S. Subsidiary and Collaboration with the Baruch S. Blumberg Institute 2019-04-08 20:00
Antengene Corporation Raises $120 Million in Series B Financing 2019-01-02 08:45
1 4 5 6 7 8